Related references
Note: Only part of the references are listed.Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk
Kelly L. Harris et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2020)
Next-Generation Genotoxicology: Using Modern Sequencing Technologies to Assess Somatic Mutagenesis and Cancer Risk
Jesse J. Salk et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2020)
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
Carole L. Yauk et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
The mutational landscape of normal human endometrial epithelium
Luiza Moore et al.
NATURE (2020)
Quantification of cancer driver mutations in human breast and lungDNAusing targeted, error-correctedCarcSeq
Kelly L. Harris et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2020)
The mutational signature profile of known and suspected human carcinogens in mice
Laura Riva et al.
NATURE GENETICS (2020)
Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology
Meagan B. Myers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan
Jesse J. Salk et al.
CELL REPORTS (2019)
Age-related remodelling of oesophageal epithelia by mutated cancer drivers
Akira Yokoyama et al.
NATURE (2019)
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Jesse J. Salk et al.
NATURE REVIEWS GENETICS (2018)
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium
Kazuaki Suda et al.
CELL REPORTS (2018)
Somatic mutant clones colonize the human esophagus with age
Inigo Martincorena et al.
SCIENCE (2018)
Selective Pressures on Human Cancer Genes along the Evolution of Mammals
Alberto Vicens et al.
GENES (2018)
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Zbyslaw Sondka et al.
NATURE REVIEWS CANCER (2018)
Variation in Organ-Specific PIK3CA and KRAS Mutant Levels in Normal Human Tissues Correlates With Mutation Prevalence in Corresponding Carcinomas
Barbara L. Parsons et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
Mechanisms of DNA Damage, Repair, and Mutagenesis
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
Andrew L. Young et al.
NATURE COMMUNICATIONS (2016)
Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas
Meagan B. Myers et al.
NEOPLASIA (2016)
Low-frequency KRAS mutations are prevalent in lung adenocarcinomas
Meagan B. Myers et al.
PERSONALIZED MEDICINE (2015)
Somatic mutation in cancer and normal cells
Inigo Martincorena et al.
SCIENCE (2015)
High burden and pervasive positive selection of somatic mutations in normal human skin
Inigo Martincorena et al.
SCIENCE (2015)
Only three driver gene mutations are required for the development of lung and colorectal cancers
Cristian Tomasetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A Subset of Papillary Thyroid Carcinomas Contain KRAS Mutant Subpopulations at Levels Above Normal Thyroid
Meagan B. Myers et al.
MOLECULAR CARCINOGENESIS (2014)
Detecting ultralow-frequency mutations by Duplex Sequencing
Scott R. Kennedy et al.
NATURE PROTOCOLS (2014)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Temporal Changes in K-ras Mutant Fraction in Lung Tissue of Big Blue B6C3F1 Mice Exposed to Ethylene Oxide
Barbara L. Parsons et al.
TOXICOLOGICAL SCIENCES (2013)
Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009)
Anita Friedrich et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk
C. L. Alden et al.
VETERINARY PATHOLOGY (2011)
ACB-PCR Quantification of K-RASCodon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue
Barbara L. Parsons et al.
CANCER INVESTIGATION (2010)
Oncomutations as Biomarkers of Cancer Risk
Barbara L. Parsons et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2010)
Comparison of NTP Historical Control Tumor Incidence Rates in Female Harlan Sprague Dawley and Fischer 344/N Rats
Gregg E. Dinse et al.
TOXICOLOGIC PATHOLOGY (2010)
The stability of historical control data for common neoplasms in laboratory rats: adrenal gland (medulla), mammary gland, liver, endocrine pancreas, and pituitary gland
H Tennekes et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2004)
Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment
PB McKinzie et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2001)
Share Paper
